Peptide receptor radionuclide therapy for aggressive atypical pituitary adenoma/carcinoma: variable clinical response in preliminary evaluation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peptide receptor radionuclide therapy for aggressive atypical pituitary adenoma/carcinoma: variable clinical response in preliminary evaluation
Authors
Keywords
Pituitary carcinoma, Atypical pituitary adenoma, Peptide receptor radionuclide therapy, Lutetium
Journal
Pituitary
Volume 17, Issue 6, Pages 530-538
Publisher
Springer Nature
Online
2013-12-09
DOI
10.1007/s11102-013-0540-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Physiological and tumoral uptake of 68Ga-DOTATATE: standardized uptake values and challenges in interpretation
- (2013) Serkan Kuyumcu et al. ANNALS OF NUCLEAR MEDICINE
- Detection of paranasal ectopic adrenocorticotropic hormone-secreting pituitary adenoma by Ga-68-DOTANOC positron-emission tomography-computed tomography
- (2013) Johannes A. Veit et al. LARYNGOSCOPE
- Peptide receptor radionuclide therapy in a patient with disabling non-functioning pituitary adenoma
- (2013) Jan Komor et al. Pituitary
- Semiquantitative Analysis and Characterization of Physiological Biodistribution of 68Ga-DOTA-TATE PET/CT
- (2012) Jolanta Kunikowska et al. CLINICAL NUCLEAR MEDICINE
- Temozolomide in aggressive pituitary adenomas and carcinomas
- (2012) LD Ortiz et al. Clinics
- PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma
- (2012) Heribert Hänscheid et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in Nonfunctioning Pituitary Adenomas: A High Throughput TMA, Immunohistochemical Study
- (2012) Claudia Ramírez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine Cancers
- (2012) Linda Villard et al. JOURNAL OF CLINICAL ONCOLOGY
- Response Assessment Using 18F-FDG PET Early in the Course of Radiotherapy Correlates with Survival in Advanced-Stage Non-Small Cell Lung Cancer
- (2012) W. van Elmpt et al. JOURNAL OF NUCLEAR MEDICINE
- First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment
- (2012) S. Baldari et al. Pituitary
- 68Ga-DOTATOC PET/CT and somatostatin receptor (sst1–sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax
- (2011) Christian Boy et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Therapy of aggressive pituitary tumors
- (2011) Annamaria Colao et al. EXPERT OPINION ON PHARMACOTHERAPY
- PET-Based Treatment Response Evaluation in Rectal Cancer: Prediction and Validation
- (2011) Marco H.M. Janssen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case–control study
- (2011) Alessandra Fusco et al. Pituitary
- Anti-VEGF therapy in pituitary carcinoma
- (2011) Leon D. Ortiz et al. Pituitary
- Atypical pituitary adenomas: incidence, clinical characteristics, and implications
- (2010) Gabriel Zada et al. JOURNAL OF NEUROSURGERY
- 68Ga-DOTATATE PET/CT for the Early Prediction of Response to Somatostatin Receptor-Mediated Radionuclide Therapy in Patients with Well-Differentiated Neuroendocrine Tumors
- (2010) A. R. Haug et al. JOURNAL OF NUCLEAR MEDICINE
- Pituitary tumours: The sst/D2 receptors as molecular targets
- (2010) Leo J. Hofland et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Role of Somatostatin Receptors in Normal and Tumoral Pituitary Corticotropic Cells
- (2010) Leo J. Hofland et al. NEUROENDOCRINOLOGY
- Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma
- (2009) Mirco Bartolomei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- KI-67 IN PITUITARY NEOPLASMS
- (2009) Fateme Salehi et al. NEUROSURGERY
- PET versus SPECT: strengths, limitations and challenges
- (2009) Arman Rahmim et al. NUCLEAR MEDICINE COMMUNICATIONS
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search